[elfsight_social_share_buttons id=”1″]

A new observational study conducted on 255 patients by Saint Barnabas Medical Center in New Jersey, seems to suggest that the drug hydroxychloroquine, along with zinc, increases the survival rate among ventilated COVID-19 patients by 200%.